coxsackievirus a9
Recently Published Documents


TOTAL DOCUMENTS

58
(FIVE YEARS 1)

H-INDEX

22
(FIVE YEARS 1)

Viruses ◽  
2020 ◽  
Vol 12 (1) ◽  
pp. 68 ◽  
Author(s):  
Eero Hietanen ◽  
Petri Susi

Coxsackievirus A9 (CVA9) is an enterically transmitted enterovirus and one of the most pathogenic type among human enteroviruses. CVA9 isolates use a distinctive RGD (Arg-Gly-Asp) motif within VP1 capsid protein that defines its ability to bind to integrin receptor(s) for cellular entry. To investigate CVA9 evolution and pathogenicity, genetic relationships and recombination events were analyzed between 54 novel clinical isolates of CVA9, as well as 21 previously published full length CVA9 sequences from GenBank. Samples were investigated by partial sequencing of the novel VP1 and 3Dpol genes, as well as including the corresponding areas from GenBank sequences. Phylogenetic analyses were combined with clinical data in a further attempt to analyze whether sequence evolution reflects CVA9 pathogenicity in the phylogenies. Furthermore, VP1 gene was also analyzed for receptor binding sites including the RGD motif and the putative heparan sulfate (HS) site. Analysis of the 559-nucleotide-long VP1 sequences identified six clades. Although most of the strains within each clade showed geographical clustering, the grouping pattern of the isolates in the analysis of the VP1 gene was strikingly different from grouping of 3Dpol, which suggests that recombination events may have occurred in the region encoding the nonstructural proteins. Inclusion of clinical data did not provide any evidence of symptom based phylogenetic clustering of CVA9 isolates. Amino acid sequence analysis of the VP1 polypeptide demonstrated that the RGD motif was fully conserved among the isolates while the putative HS binding site was only found in one isolate. These data suggest that integrin binding is essential for virus tropism, but do not explain the symptom repertoire.


2019 ◽  
Vol 64 (3) ◽  
pp. 132-139
Author(s):  
P. S. Usoltseva ◽  
A. V. Alimov ◽  
A. V. Rezaykin ◽  
A. G. Sergeev ◽  
A. V. Novoselov

The aim of this study was to determine the role of the human neonatal receptor for the Fc fragment of IgG (hFcRn) as a common uncoating cellular receptor for echoviruses and coxsackievirus A9 during infection of human rhabdomyosarcoma (RD) cells. Material and methods. The protective effect of the human serum albumin, purified from globulins, (HSA-GF) and antibodies to hFcRn was studied in RD cells infected with several strains and clones of species B enteroviruses possessing different receptor specificity (echoviruses 3, 9, 11, 30 and coxsackieviruses A9, B4, B5). Results. It was shown that HSA-GF at concentrations of 4% or less protected RD cells from infection with echoviruses 3, 9, 11 and coxsackievirus A9. The antibodies to hFcRn at concentrations of 2.5 ug/mL or less demonstrated the similar spectrum of protective activity in RD cells against infection with echoviruses 3, 9, 11, 30 and coxsackievirus A9. The protective effect of HSA-GF or the antibodies to hFcRn was not observed in RD cells infected with coxsackieviruses B4 and B5 that need coxsackievirus-adenovirus receptor for uncoating. Discussion. The usage of the previously characterized echovirus 11 clonal variants with different receptor specificity allowed us to define the function of hFcRn as a canyon-binding uncoating receptor in RD cells. The kinetics and magnitude of the observed protective effects correlated with receptor specificity of the enteroviruses used in this work supporting the two-step interaction of DAF-dependent echoviruses with the cellular receptors. Conclusions. In this study, the function of hFcRn was defined in RD cells as a canyon-binding and uncoating receptor for echoviruses and coxsackievirus A9. The two-step interaction of DAF-dependent echoviruses during entry into the cells was confirmed: initially with the binding receptor DAF and subsequently with the uncoating receptor hFcRn.


2016 ◽  
Vol 13 (1) ◽  
Author(s):  
Outi Heikkilä ◽  
Pirjo Merilahti ◽  
Marika Hakanen ◽  
Eveliina Karelehto ◽  
Jonna Alanko ◽  
...  

2014 ◽  
Vol 88 (9) ◽  
pp. 5138-5151 ◽  
Author(s):  
M. Huttunen ◽  
M. Waris ◽  
R. Kajander ◽  
T. Hyypia ◽  
V. Marjomaki

2013 ◽  
Vol 87 (7) ◽  
pp. 3943-3951 ◽  
Author(s):  
S. Shakeel ◽  
J. J. T. Seitsonen ◽  
T. Kajander ◽  
P. Laurinmaki ◽  
T. Hyypia ◽  
...  

2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Yi-Chuan Huang ◽  
Ying-Hsia Chu ◽  
Ting-Yu Yen ◽  
Wen-Chan Huang ◽  
Li-Min Huang ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-9 ◽  
Author(s):  
Pirjo Merilahti ◽  
Satu Koskinen ◽  
Outi Heikkilä ◽  
Eveliina Karelehto ◽  
Petri Susi

Picornaviruses that infect humans form one of the largest virus groups with almost three hundred virus types. They include significant enteroviral pathogens such as rhino-, polio-, echo-, and coxsackieviruses and human parechoviruses that cause wide range of disease symptoms. Despite the economic importance of picornaviruses, there are no antivirals. More than ten cellular receptors are known to participate in picornavirus infection, but experimental evidence of their role in cellular infection has been shown for only about twenty picornavirus types. Three enterovirus types and one parechovirus have experimentally been shown to bind and use integrin receptors in cellular infection. These include coxsackievirus A9 (CV-A9), echovirus 9, and human parechovirus 1 that are among the most common and epidemic human picornaviruses and bind toαV-integrins via RGD motif that resides on virus capsid. In contrast, echovirus 1 (E-1) has no RGD and uses integrinα2β1 as cellular receptor. Endocytosis of CV-A9 has recently been shown to occur via a novel Arf6- and dynamin-dependent pathways, while, contrary to collagen binding, E-1 binds inactiveβ1 integrin and enters via macropinocytosis. In this paper, we review what is known about receptors and endocytosis of integrin-binding human picornaviruses.


2012 ◽  
Vol 65 (4) ◽  
pp. 367-369 ◽  
Author(s):  
Yoko Aoki ◽  
Akiko Abe ◽  
Tatsuya Ikeda ◽  
Chieko Abiko ◽  
Katsumi Mizuta ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document